Dr. Elias Jabbour serves as Professor of Medicine and Chief of the Acute Lymphoblastic Leukemia (ALL) Section within the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas. His research is centered on translational and clinical developmental therapeutics in leukemia, with a particular emphasis on advancing novel treatment paradigms across disease subtypes.
Over the past two decades, Dr. Jabbour has made seminal contributions that have significantly enhanced prognosis, survival outcomes, and therapeutic strategies for patients with various forms of leukemia. His work is reflected in an extensive body of scholarship, with more than 1,000 peer-reviewed publications, underscoring his leadership and impact in the field of hematologic malignancies.